The Medline Company Announces the Reimbursement Launch of the SIBIONICS GS1 Device by EOPYY for Patients with Type 1 Diabetes and Gestational Diabetes
Athens, 5/5/2025
The Medline Company is pleased to announce that, as of May 5, 2025, the …
Launch of Strategic Partnership with Nanjing Shouliang-Med
The MEDLINE Company is pleased to announce the launch of a strategic partnership with Nanjing …
We are now one year closer to achieving our goals.
“The Medline company” started its journey in the sensitive and demanding healthcare market on 27 …
